System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Guillaume Marliot is an expert in Pharmacy at Centre Oscar Lambret (France). Guillaume Marliot has authored 29 publications, the most recent in 2025. SLR score: 74 (community average: 125). How the SLR is computed.

LeadR Profile

Guillaume Marliot Centre Oscar Lambret France
74 ScienceLeadR Reputation 74

Unlock

Register Login
Network Map

Pharmacy

Subspecialties: Oncology - Public Health - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2010 - 2025
Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 29

Citations

Citations: 158 1st author: 3 Last author: 12 Unique author: 0

Main journals

J Oncol Pharm Pract 6
Bull Cancer 4
J Clin Oncol 4
Section 5: Patient safety and quality assurance 2
˜Le œpharmacien clinicien 2

Best Journals

J Clin Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Transportation of protein drugs at hospital: Comparison of mechanical stress occurring during pneumatic transportation and hand-carried transport.
PMID 40049322 — pharmaceutical preparations, stress, physiological, pharmacy, transportation		J Pharm Sci20250
Securing the oral and enteral oncopediatric chemotherapy process in pediatric oncology: Introduction of the ENFit™ standard in a controlled-atmosphere area and implementation of a dispensing service of medications to outpatients circuit with advice on proper use.
PMID 38613327 — patient care, medical oncology, syringes, pediatrics, pharmacy, drug therapy, caregivers, atmosphere, outpatients, chemotherapy		J Oncol Pharm Pract20240
Grade 3 cytolysis in a patient with metastatic colorectal cancer consuming a mushroom powder-based alternative therapy.
PMID 39223928 — pharmaceutical services, cholestasis, powders, pharmaceutical preparations, neoplasms, dietary supplements, pharmacy, drug therapy, liver, neoplasm metastasis, agaricales, therapeutics, medical oncology, colorectal neoplasms, complementary therapies, chemotherapy		J Oncol Pharm Pract20241
5PSQ-123 Simulation of a discharge control: an effective tool for qualifying staff
OpenAlex W4393005315		Section 5: Patient safety and quality assurance20240
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study).
PMID 37438439 — ranitidine, injections, histamine, incidence, paclitaxel, hypersensitivity, premedication, drug therapy, pharmacology		Eur J Clin Pharmacol20233

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS